Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
ATOMO DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
Di | ATOMO DIAGNOSTICS LIMITED: Atomo Appoints Chair | - | ASX | ||
29.08. | ATOMO DIAGNOSTICS LIMITED: Atomo Investor Webinar Presentation | - | ASX | ||
29.08. | ATOMO DIAGNOSTICS LIMITED: FY25 Results Presentation | - | ASX | ||
29.08. | ATOMO DIAGNOSTICS LIMITED: 2025 Appendix 4G and Corporate Governance Statement | - | ASX | ||
29.08. | ATOMO DIAGNOSTICS LIMITED: 2025 Appendix 4E and Annual Report | - | ASX | ||
21.08. | ATOMO DIAGNOSTICS LIMITED: Update on Indicated Pascal Supply for FebriDx | - | ASX | ||
19.08. | ATOMO DIAGNOSTICS LIMITED: Trading Halt | 1 | ASX | ||
19.08. | ATOMO DIAGNOSTICS LIMITED: Pause in Trading | - | ASX | ||
15.08. | ATOMO DIAGNOSTICS LIMITED: Notification regarding unquoted securities - AT1 | - | ASX | ||
15.08. | ATOMO DIAGNOSTICS LIMITED: Application for quotation of securities - AT1 | - | ASX | ||
13.08. | ATOMO DIAGNOSTICS LIMITED: Successful Placement from Share Purchase Plan Shortfall | - | ASX | ||
07.08. | ATOMO DIAGNOSTICS LIMITED: Atomo secures order for Pascal worth US$410,000 from Lumos | - | ASX | ||
29.07. | ATOMO DIAGNOSTICS LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
25.07. | ATOMO DIAGNOSTICS LIMITED: Atomo Investor Webinar Presentation | - | ASX | ||
24.07. | ATOMO DIAGNOSTICS LIMITED: Change in substantial holding | - | ASX | ||
24.07. | ATOMO DIAGNOSTICS LIMITED: Notification regarding unquoted securities - AT1 | 1 | ASX | ||
24.07. | ATOMO DIAGNOSTICS LIMITED: Application for quotation of securities - AT1 | 1 | ASX | ||
21.07. | Atomo Diagnostics Completes Share Purchase Plan Shortfall Placement | 1 | Finance News Network | ||
21.07. | Atomo Diagnostics Completes Shortfall Placement After Share Purchase Plan | 1 | Finance News Network | ||
21.07. | ATOMO DIAGNOSTICS LIMITED: Successful Placement from Share Purchase Plan Shortfall | - | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GLUCOTRACK | 10,590 | +117,45 % | Glucotrack, Inc. - 8-K, Current Report | ||
PROCEPT BIOROBOTICS | 37,140 | -3,88 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
ATRICURE | 35,070 | -6,63 % | AtriCure begins rollout of cryoXT cryoablation tech for post-operative pain after amputation | ||
ALIGNMENT HEALTHCARE | 16,030 | -1,96 % | Alignment Healthcare, Inc. - 8-K, Current Report | ||
FRESENIUS MEDICAL CARE | 42,600 | +0,24 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 26,460 | -5,47 % | BrightSpring Health: UBS bestätigt Kaufempfehlung angesichts starker Wachstumsaussichten | ||
UNITEDHEALTH | 301,95 | +0,35 % | UnitedHealth Group-Aktie: Kurs legt zu (283,70 €) | Das Wertpapier der UnitedHealth Group notiert heute etwas fester. Zuletzt zahlten Investoren für das Wertpapier 283,70 Euro. Das Wertpapier der UnitedHealth Group verzeichnet derzeit einen Preisanstieg... ► Artikel lesen | |
FRESENIUS | 46,930 | +0,84 % | Fresenius platziert Anleihen im Volumen von 1 Milliarde Euro | DJ Fresenius platziert Anleihen im Volumen von 1 Milliarde Euro
DOW JONES--Fresenius hat nach fast zweijähriger Abwesenheit vom Euro-Anleihemarkt zwei Anleihen im Gesamtvolumen von 1 Milliarde... ► Artikel lesen | |
KINDLY MD | 2,770 | -29,78 % | KindlyMD, Inc: KindlyMD Approved for Options Trading on Nasdaq | SALT LAKE CITY, UT / ACCESS Newswire / September 10, 2025 / KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin treasury vehicle via... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,790 | +0,36 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
BETA BIONICS | 26,410 | +4,10 % | Beta Bionics, Inc.: Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
KESTRA MEDICAL TECHNOLOGIES | 21,820 | +18,59 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for... ► Artikel lesen | |
NUTEX HEALTH | 96,70 | +5,11 % | Nutex Health, Inc.: Nutex Health Provides Financial Reporting Update | HOUSTON, Aug. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 22,780 | -0,57 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
ECKERT & ZIEGLER | 17,430 | +1,51 % | EQS-News: Eckert & Ziegler SE: Berenberg startet Coverage mit "Kauf"-Empfehlung und Kursziel von 24 € - Kurspotenzial 47% | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Research Update
Eckert & Ziegler: Berenberg startet Coverage mit "Kauf"-Empfehlung und Kursziel von 24 € - Kurspotenzial 47%
09.09.2025... ► Artikel lesen |